<DOC>
	<DOC>NCT01789021</DOC>
	<brief_summary>In this clinical trial, accuracy evaluation of Bayer Contour XT blood glucose monitoring system and blood glucose monitoring systems from other companies across the overall tested glucose range will be performed.</brief_summary>
	<brief_title>Analytical Performance Evaluation of Blood Glucose Monitoring Systems- Investigator Sponsored ContourÂ® XT Comparator Study - Ulm Germany</brief_title>
	<detailed_description />
	<criteria>18 years of age or older Male or female subjects with type 1 or type 2 diabetes or healthy subjects For BG adjustment people with type 1 diabetes Severe acute illness that, in the opinion of the Investigator, might pose additional risk to the patient Chronic illness that, in the opinion of the Investigator, might pose additional risk to the patient Current condition that, in the opinion of the Investigator, doesn't enable subject to participate in the study For BG adjustment people with type 1 diabetes without CHD, condition after myocardial infarction, PAOD, cerebral events or hypoglycaemia unawareness Legal incompetence or limited legal competence Age &lt; 18 years Dependency from the sponsor or the clinical investigator Mental incapacity or language barriers precluding adequate compliance with the study procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>blood glucose monitoring systems</keyword>
	<keyword>ISO 15197</keyword>
	<keyword>system accuracy</keyword>
</DOC>